SCHEMBL6208060

SCHEMBL6208060

Fc1cc(F)c(F)c(Nc2n[nH]c3cc(Cl)c(-c4ccccc4)cc23)c1F.Fc1ccc(Nc2n[nH]c3cc(Cl)c(-c4ccccc4)cc23)cc1F

nearest known ligand 0.55

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 7/20 0.55
GSK3B P49841 4/20 0.51
CDK1 P06493 1/20 0.47
CDK2 P24941 1/20 0.47
GRM4 Q14833 3/20 0.43
FADS1 O60427 4/20 0.43
CYP1A2 P05177 2/20 0.41
MAPK8 P45983 1/20 0.40
MAPK10 P53779 1/20 0.40
MAPK14 Q16539 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4494950 0.93 TRPA1 (0.62) TRPA1GSK3BCDK1CDK2GRM4
SCHEMBL4496261 0.92 GSK3B (0.56) TRPA1GSK3BCDK1CDK2FADS1
SCHEMBL4508742 0.85 GSK3B (0.58) GSK3BCDK1CDK2FADS1CYP1A2
SCHEMBL1375699 0.84 GSK3B (0.52) TRPA1GSK3BCDK1CDK2GRM4
SCHEMBL4510158 0.82 GSK3B (0.60) TRPA1GSK3BCDK1CDK2GRM4
SCHEMBL4500190 0.81 GSK3B (0.56) TRPA1GSK3BCDK1CDK2FADS1
SCHEMBL4497901 0.80 GSK3B (0.70) TRPA1GSK3BCDK1CDK2FADS1
SCHEMBL2333075 0.77 GSK3B (0.57) TRPA1GSK3BCDK1CDK2GRM4
SCHEMBL4498900 0.77 TRPA1 (0.59) TRPA1GSK3BCDK1CDK2FADS1
SCHEMBL4509554 0.75 FADS1 (0.59) TRPA1GSK3BCDK1CDK2GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537087-A1 NOVEL AMINOINDAZOLE DERIVATIVES AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Aventis Pharma S.A. (FR) 2005-06-08 EP disclosed
WO-2004022544-A1 NOVEL AMINOINDAZOLE DERIVATIVES AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA S.A. (FR) 2004-03-18 WO disclosed